Highlights uniQure N.V.

Equities

QURE

NL0010696654

Real-time Estimate Cboe BZX Other stock markets 01:22:07 2024-05-17 pm EDT			5-day change	1st Jan Change
5.04 ^USD	-0.59%		+2.24%	-25.70%

May. 08	Mizuho Adjusts uniQure's Price Target to $6 From $7, Keeps Neutral Rating	MT
May. 07	UniQure N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UniQure N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Earnings Flash (QURE) UNIQURE Reports Q1 Revenue $8.5M	May. 07	MT
UniQure N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
UniQure N.V. Announces Update on Phase I/II Clinical Trials of Amt-130Gene Therapy for the Treatment of Huntington's Disease	Dec. 19	CI
UniQure Says US FDA Clears Investigational New Drug Application for Fabry Disease Candidate	Nov. 29	MT
UniQure N.V. Announces FDA Clearance of Investigational New Drug Application for Amt-191 Gene Therapy for Fabry Disease	Nov. 29	CI
Worldwide Healthcare Trust net asset value slips in volatile markets	Nov. 23	AN
UniQure N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (QURE) UNIQURE Posts Q3 Revenue $1.4M	Nov. 07	MT
UniQure N.V. Announces Major Presence at the European Society of Gene and Cell Therapy Annual Meeting	23-10-24	CI
UniQure Says FDA Clears Investigational New Drug Application for Mesial Temporal Lobe Epilepsy Therapy	23-09-05	MT
UniQure N.V. Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy	23-09-05	CI
UniQure N.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-01	CI
Earnings Flash (QURE) UNIQURE Posts Q2 Revenue $2.4M	23-08-01	MT
UniQure to Sell Royalty Stake in Hemgenix for Up to $400 Million	23-05-15	MT
Earnings Flash (QURE) UNIQURE Reports Q1 Revenue $5.3M	23-05-09	MT
UniQure N.V. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
UniQure Swings to 2022 Loss, Revenue Drops	23-02-27	MT
UniQure N.V. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
UniQure N.V. Announces HOPE-B Clinical Trial Data Published in the New England Journal of Medicine, Demonstrating Durability and Other Benefits of HEMGENIX (Etranacogene Dezaparvovec-Drlb)	23-02-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights uniQure N.V.

Equities

QURE

NL0010696654

Highlights

Filters